The CORBEVAX vaccine was developed with global access in mind. It is a low-cost, easy-to-produce and -transport vaccine and the $7 million needed for development was provided by philanthropists.
from HowStuffWorks - Learn How Everything Works! https://ift.tt/3qKESSa
Wednesday, January 19, 2022
Subscribe to:
Post Comments
(
Atom
)
No comments :
Post a Comment